ConductScience.org, home

Paper7105380

Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.

Hill BT and 1 other. Cancer Chemother Pharmacol, 1982. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities. Papers, record 7105380. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7105380

Download JSON
Cell line
L5178Y VCRR1 paper
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1982
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.34
iCite
Revised in PubMed
2026-10-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hill BTB T
2Whelan RDR D

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
LymphocytesMajor topic
Neoplasms, ExperimentalMajor topic
VinblastineMajor topic
VincristineMajor topic
Animals
Cell Line
Drug Resistance
Mice
Vindesine

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1986302The value of adriamycin in overcoming resistance to methotrexate in tissue culture.Eur J Cancer (1965)1976https://conductscience.org/library/papers/986302PubMed
2412968Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.J Med Chem1978https://conductscience.org/library/papers/412968PubMed
37454202The mode of action of Vinca alkaloids.Oncology1980https://conductscience.org/library/papers/7454202PubMed
4287570An initial report of a phase-III trial comparing vindesine and vincristine for acute lymphocytic leukemia of childhood.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/287570PubMed
5679195Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in culture.Cancer Res1978https://conductscience.org/library/papers/679195PubMed
66943380Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines.J Natl Cancer Inst1981https://conductscience.org/library/papers/6943380PubMed
7281559Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D.J Natl Cancer Inst1978https://conductscience.org/library/papers/281559PubMed
87375474Partial cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to 4'-demethylepipodophyllotoxin ethylidene-beta-D-glucoside.Proc Soc Exp Biol Med1980https://conductscience.org/library/papers/7375474PubMed
9709548Vindesine: a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumors.Cancer Treat Rep1978https://conductscience.org/library/papers/709548PubMed
101168475Uptake and binding of vincristine by murine leukemia cells.Biochem Pharmacol1975https://conductscience.org/library/papers/1168475PubMed
116947891Concepts for controlling drug-resistant tumor cells.Eur J Cancer (1965)1980https://conductscience.org/library/papers/6947891PubMed
137296754Experimental in vivo cross-resistance of vinca alkaloid drugs.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7296754PubMed
14144604Flow microfluorometric estimation of G1 and G2 chalone inhibition of the JB-1 tumour cell cycle in vitro.Exp Cell Res1977https://conductscience.org/library/papers/144604PubMed
156953266Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.J Natl Cancer Inst1982https://conductscience.org/library/papers/6953266PubMed
161083340Methotrexate resistance and uptake of DDMP by L5178Y cells. Selective protection with folinic acid.Eur J Cancer (1965)1975https://conductscience.org/library/papers/1083340PubMed
175464247Altered glycosidase levels in drug-resistant mouse leukemias.Mol Pharmacol1970https://conductscience.org/library/papers/5464247PubMed
187448818Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors.Cancer Treat Rep1980https://conductscience.org/library/papers/7448818PubMed
19455584Vindesine as a single agent in the treatment of advanced malignant melanoma.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/455584PubMed
207438119Phase I and II studies of vindesine.Cancer Treat Rev1980https://conductscience.org/library/papers/7438119PubMed
217214365Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.Cancer Res1981https://conductscience.org/library/papers/7214365PubMed

See all 27 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
9740539Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.Invest New Drugs1998https://conductscience.org/library/papers/9740539PubMed
7765329Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro.Cytotechnology1993https://conductscience.org/library/papers/7765329PubMed
6090762Vindesine/cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung.Klin Wochenschr1984https://conductscience.org/library/papers/6090762PubMed
4006052Decreased retention of vinca alkaloids in chronic lymphatic leukemia cells from refractory patients.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/4006052PubMed
3858013Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/3858013PubMed
3621454Selective interactions of verapamil with anthraquinones in adriamycin-sensitive and -resistant murine and human tumour cell lines in vitro.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3621454PubMed
3583643Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugs.Invest New Drugs1986https://conductscience.org/library/papers/3583643PubMed
3390658Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.Br J Pharmacol1988https://conductscience.org/library/papers/3390658PubMed
2924371Comparative effectiveness of mitoxantrone and doxorubicin in overcoming experimentally induced drug resistance in murine and human tumour cell lines in vitro.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2924371PubMed
1657846Characterization of an etoposide-resistant human K562 cell line, K/eto.Jpn J Cancer Res1991https://conductscience.org/library/papers/1657846PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7105380

GET https://conductscience.org/api/papers/v1/7105380/references?page=2